首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 製藥 > 癌症 > 歐洲肺癌治療市場
產業/市場分類
製藥 (4452)
肥胖症治療 (48)
非專利藥 (117)
疫苗 (167)
神經疾病 (175)
骨頭疾病治療 (40)
動物用醫藥 (18)
處方藥 (89)
規章 (107)
感染疾病 (315)
精神病 (80)
製藥企業 (500)
糖尿病 (157)
癌症 (837)
藥物開發 (1246)
DDS (173)
OTC 非處方藥 (147)
市場調查報告書

歐洲肺癌治療市場

European Lung Cancer Therapeutics Markets

出版商 Frost & Sullivan
出版日期 2008年06月 商品編碼 68556
內容資訊 英文  
價格
US $ 6500 Web Access (Regional License)
US $ 7000 Hard Copy & Web Access (Regional License)


歐洲肺癌治療市場 是由出版商Frost & Sullivan在2008年06月所出版的。 這份英文市場調查報告書價格從美金6500起跳。

目錄

Abstract

This research service analyses the European Lung cancer therapeutics market. It analyses market drivers, restraints and challenges faced by industry participants. Revenue forecasts and pipeline analysis has been discussed. It also provides strategic recommendations.

Table of Contents

1. EXECUTIVE SUMMARY

Overview

  • Overview of the European Lung Cancer Therapeutics Markets

2. GLOSSARY OF TERMS

List of Terms

  • Abbreviations

3. RESEARCH METHODOLOGY

Research Objectives and Scope

  • Methodology
  • Assumptions and Limitations

4. MARKET OVERVIEW

Introduction

  • Disease Characteristics
  • Epidemiology

5. INDUSTRY CHALLENGES

Industry Challenges for the European Lung Cancer Therapeutics Market

  • Challenges Faced by Pharmaceutical and Biotech Companies

6. TOTAL EUROPEAN LUNG CANCER THERAPEUTICS MARKET

Overview and Definitions

  • Introduction
  • Market Drivers
  • Market Restraints
  • Current Therapeutic Options
  • Future Therapeutic Approaches
  • Market Engineering Measurement Analysis

Competitive Analysis

  • Pipeline Analysis

7. TOTAL FORECASTS FOR THE EUROPEAN LUNG CANCER THERAPEUTICS MARKET

Forecasts

  • Patient Forecasts
  • Market Revenue Forecasts
  • Geographical Trends

8. PRICING AND REIMBURSEMENTS

Pricing and Reimbursements Issues

  • Pricing and Reimbursements in Europe

9. STRATEGIC RECOMMENDATIONS FOR THE EUROPEAN LUNG CANCER THERAPEUTICS MARKET

Market Engineering Recommendations

  • Strategic Recommendations

10. DATABASE OF KEY INDUSTRY PARTICIPANTS

Key Industry Participants

  • Key Participants in the Lung Cancer Therapeutics Market

11. DECISION SUPPORT DATABASES

Habitual Indicators

  • Prevalence of Smokers
  • Prevalence of Male Smokers
  • Prevalence of Female Smokers
  • Per Capita Consumption of Cigarette
  • Pharmaceutical R&D Expenditure as a Percentage of Pharmaceutical Market
Back to Top